investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors
Michelle Hildebrandt
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Michelle Hildebrandt
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
Bryan Q Spring
Online monitoring and image-guided treatment of chemoresistant micrometastases
Ovary
Pathology
Meir Stampfer
Dietary and Hormonal Determinants of Cancer in Women
Ovary
Celeste Leigh Pearce
Mechanisms of Prevention of Ovarian Cancer by Oral Contraceptives
Ovary
Pathology
Charles D Blanke
SWOG Network Group Operations Center of the NCTN
Ovary
Charles Drescher
Pacific Ovarian Cancer Research Consortium
Ovary
Daniel W Cramer
Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens
Ovary
Pathology
Gary Gilliland
Cancer Center Support Grant (comprehensive)
Ovary
Prisca O Adejumo
Effects of Genetic Education on Nurses Competencies in Counseling People With Family History of Cancer and the Establishment of Cancer Risk Clinic in Selected Hospitals in Nigeria
Ovary
Joanne F Dorgan
Prospective Study of Serum MIS and Gynecologic Cancer Risk
Ovary